Hanmi's Global Presence

Home > Business Development > Hanmi's Global Presence

Hanmi Pharmaceutials. has been producing Cephalosporin products since 1987 and supplying it to more than 100 customers in over 40 countries all over the world. In Europe, Hanmi has been supplying it to customers in UK, Germany, France, Italy, Spain, Slovenia, and Poland. In Asia-Pacific region, Hanmi’s customers are in Japan, Thailand, Indonesia, India, Pakistan, Turkey, Jordan, and Iran. In the American region, Hanmi has customers in USA, Mexico, Argentina, Brazil, Colombia, and Chile.

World Business Relationship

Newly built manufacturing plants also offer Hanmi an ability to produce several key innovative drug APIs and intermediates. Hanmi has been working with its partners to export key innovative drug APIs and intermediates to global market. Hanmi is also quite interested in CMO opportunities with its potential global partners for Cephalosporin API, finished product, both oral and injectables, as well as innovative drug APIs and key intermediates.

Hanmi also has been active in working with global partners in exporting its IMDs (incrementally modified drugs) such as esomeprazole, sibutramine, clopidogrel, amlodipine, atorvastatin, etc. Hanmi has been working vigorously to find business partners in other parts of the world for its numerous IMDs. Hanmi has been searching and considering partnership opportunities with its Platform technologies and products in its developmental pipeline which includes LAPSCOVERY (Long-Acting Protein/Peptide Technology) and ORASCOVERY (Oral Oncology Product Technology).

※ We hope you get to know us through this website. Please contact us if you have any questions or to opinions using the following link : contact us